Orexo AB announced new topline results of 2 clinical trials with a combination of buprenorphine and naloxone for buprenorphine induction and plans to pursue approval of an expanded label in the US. Medscape Medical News (Source: Medscape Medical News Headlines)
Positive Results With Combo Tx for Opioid Dependence Positive Results With Combo Tx for Opioid Dependence
Previous post: Suboxone: What is it?
Next post: Houston Pain Management Now Offering Outpatient Drug Rehab with a…